← Back to Search

Virus Therapy

Convalescent COVID 19 Plasma for COVID-19

Phase < 1
Waitlist Available
Led By Dean J Kereiakes, MD
Research Sponsored by The Christ Hospital
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up at day 28
Awards & highlights

Study Summary

This trial is looking at using plasma from people who have recovered from Covid-19 to treat people who are hospitalized with it. The goal is to see if this can help reduce mortality rates and the need for mechanical ventilation.

Eligible Conditions
  • COVID-19

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~at day 28
This trial's timeline: 3 weeks for screening, Varies for treatment, and at day 28 for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Reduce mortality
Secondary outcome measures
Reduce requirement for mechanical ventilation.
Reduce the duration of mechanical ventilation.
Review of treatment related adverse events.

Trial Design

1Treatment groups
Experimental Treatment
Group I: Convalescent COVID 19 PlasmaExperimental Treatment1 Intervention
Subjects will receive and intravenous infusion of 500 mls of Convalescent COVID 19 Plasma.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Convalescent COVID 19 Plasma
2020
Completed Early Phase 1
~30

Find a Location

Who is running the clinical trial?

The Christ HospitalLead Sponsor
19 Previous Clinical Trials
1,371 Total Patients Enrolled
Dean J Kereiakes, MDPrincipal InvestigatorThe Christ Hospital
6 Previous Clinical Trials
7,826 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
clinicaltrials.govStudy
CoVID-19 Plasma in Treatment of COVID-19 Patients
Dean Kereiakes 2020. "CoVID-19 Plasma in Treatment of COVID-19 Patients". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04355897.
~4 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top